March 2, 2012 — Idiopathic intracranial hypertension (IIH; also called pseudotumor cerebri [PTC] or benign intracranial hypertension) is surprisingly common in patients with systemic lupus ...

Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. Magnetic Resonance Imaging ...

Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes, may be a potential treatment for idiopathic intracranial hypertension (IIH). In a small phase 2 trial, ...

GLP-1 RAs were associated with positive effects on intracranial hypertension management, including reduced symptoms and treatment burden.

A drug used for type 2 diabetes may be able to treat those with ‘blinding’ headaches. The corresponding trial was published in Brain. Blinding headaches, also known as idiopathic intracranial ...

AUSTIN, Texas — Venous manometry and neuroimaging may provide additional value when diagnosing patients who do not meet criteria for idiopathic intracranial hypertension, according to a poster ...

Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...